Omeprazole
NDC 42708-170, Omeprazole, capsule, delayed release, from QPharma Inc.
- Product NDC
- 42708-170
- Status
- Listed
- Labeler
- QPharma Inc
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075757
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42708-170 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OMEPRAZOLE20 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42708-170-14 | 42708017014 | 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE, PLASTIC (42708-170-14) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f6f6ad19-ff6a-7cd3-e053-6294a90ae1bf
Use it
Look up 42708-170 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42708-170 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42708-170. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.